General Information of Drug (ID: DMYWQ0O)

Drug Name
Tetrabenazine Drug Info
Synonyms
Nitoman; Rubigen; Tetrabenazina; Tetrabenazinum; Tetrabenzaine; Tetrabenzine; Xenazine; Tetra Benazin; Nitoman (TN); Ro 1-9569; Tetrabenazina [INN-Spanish]; Tetrabenazine (INN); Tetrabenazine [INN:BAN]; Tetrabenazinum [INN-Latin]; Xenazine (TN); Nitoman, Xenazine, Tetrabenazine; Ro 1-9569/12; 1,3,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo(a)quinolizin-2-one; 1,3,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one; 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-Benzo[a]quinolizin-2-one; 2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine; 2-Oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11-beta-hexahydro-2H-benzoquinolizine; 2-Oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11.beta.-hexahydro-2H-benzoquinolizine; 2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-(9CI); 9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one; 9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one
Indication
Disease Entry ICD 11 Status REF
Huntington disease 8A01.10 Approved [1]
Hyperkinetic movement disorder 6B60.8 Approved [1]
Therapeutic Class
Nephropathic cystinosis therapy
Cross-matching ID
PubChem CID
6018
ChEBI ID
CHEBI:64028
CAS Number
718635-93-9
TTD ID
D09PJX
VARIDT ID
DR01035
INTEDE ID
DR1567
ACDINA ID
D00667

Full List of Drug Formulations Containing This Drug

Tetrabenazine 25 mg tablet
Company Formulation ID FDA Description
Camber Pharmaceuticals F21009 Lactose monohydrate; Sodium stearyl fumarate; Ferric oxide yellow; Talc; Starch, corn
Sun Pharmaceutical Industries F21007 Anhydrous lactose; Magnesium stearate; Ferric oxide yellow; Talc; Silicon dioxide; Sodium starch glycolate type a potato; Starch, corn
Ingenus Pharmaceuticals F21008 Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Talc; Starch, corn
Lundbeck Pharmaceuticals; Oceanside Pharmaceuticals F21010 Lactose, unspecified form; Magnesium stearate; Ferric oxide yellow; Talc; Starch, corn
AvKARE; TAGI Pharma F21011 Lactose, unspecified form; Magnesium stearate; Ferric oxide yellow; Talc; Starch, corn
------------------------------------------------------------------------------------
Tetrabenazine 12.5 mg tablet
Company Formulation ID FDA Description
Camber Pharmaceuticals F21004 Lactose monohydrate; Sodium stearyl fumarate; Talc; Starch, corn
Sun Pharmaceutical Industries F21002 Anhydrous lactose; Magnesium stearate; Talc; Silicon dioxide; Sodium starch glycolate type a potato; Starch, corn
Ingenus Pharmaceuticals F21003 Lactose monohydrate; Magnesium stearate; Talc; Starch, corn
Lundbeck Pharmaceuticals; Oceanside Pharmaceuticals F21005 Lactose, unspecified form; Magnesium stearate; Talc; Starch, corn
AvKARE; TAGI Pharma F21006 Lactose, unspecified form; Magnesium stearate; Talc; Starch, corn
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4834).